Mimi is a Senior Advisor on the Frazier Life Sciences team and has over 20 years of experience in the executive search industry.
Mimi joined Frazier Healthcare Partners as a Senior Advisor in 2018, and assists with recruiting for Frazier’s Life Sciences portfolio companies.
Prior to Frazier, Mimi was a member of Spencer Stuart’s Life Sciences Practice. Her executive search experience included assignments for organizations ranging from emerging life sciences companies to multinational biotechnology, pharmaceutical and medical technology firms. She executed searches for board members, and senior executives in general management and R&D, as well as a variety of commercial, finance and business development positions.
Mimi previously served as Vice President of Operations and co-founder at Avigen, a startup gene therapy company. Prior to that, she was the Director of Cell Biology at Somatix Therapy Corporation, a publicly-held gene therapy company. Earlier in her career, Mimi worked at Triton Biosciences, where she conducted pioneering research on a novel therapeutic approach targeting the Her2 protein in breast and ovarian cancer. She began her career in healthcare with Peralta Cancer Research Institute as a staff scientist, and previously served on the board of directors of Bionovo, a public company developing novel therapeutics for breast cancer and women’s health.
In addition to her role at Frazier, Mimi is an Honorary Member of the CEO Roundtable on Cancer and serves as a strategic advisor. She also volunteers in various advisory and mentoring roles for board-ready executives, as well as career development for students in STEM programs.
Mimi received her B.A. with Honors in Biological Sciences from the University of Chicago and her Ph.D. in Genetics from the University of California at Berkeley. She was a Postdoctoral Fellow at Stanford University, where she was a recipient of a Damon Runyon-Walter Winchell Cancer Fund Fellowship.
University of California, Berkeley (Ph.D.)
University of Chicago (B.A.)